1. Verbeek P. Report on molybdenum-99 production for nuclear medicine 2010-2020 [Internet]. 2008 [accessed 6 October 2017]. https://www.oecd-nea.org/med-radio/docs/200902_AIPESMolySupplyReport.pdf.
2. European Commission. Medical Radiation Exposure of the European Population Part 1/2. Radiation Protection 180. Luxembourg: Publications Office of the European Union; 2014.
3. Nuclear Physics European Collaboration Committee (NuPECC). Nuclear Physics for Medicine [Internet]. 2014 [accessed 6 October 2017]. http://www.nupecc.org/index.php?display=npmed/npmed.
4. Council of the European Union. Council Directive 2013/59/Euratom of 5 December 2013 laying down basic safety standards for protection against the dangers arising from exposure to ionising radiation, and repealing Directives 89/618/Euratom, 90/641/Euratom, 96/29/Euratom, 97/43/Euratom and 2003/122/Euratom. Brussels: Official Journal of the European Union; 2014.
5. Arrêté du 3 février 2016 fixant les critères d’acceptabilité pour les activimètres utilisés en médecine nucléaire ainsi que les procédures concernées;Agence Fédérale de Contrôle Nucléaire,2016